BACKGROUND:Hematopoietic cell transplantation (HCT) may be detrimental to bone health and vitamin D status in children. PROCEDURE: We conducted a prospective, multicenter cohort study to identify changes in bone health markers during the first 100 days after allogeneic HCT in 26 children. Bone mineral density (BMD), bone mineral content (BMC), and serum 25-hydroxyvitamin D (25OHD) concentrations were measured at baseline, 30 days, and 100 days after HCT. RESULTS:Mean (SD) BMD and BMC Z-scores (-0.48 ± 1.09 and -0.98 ± 1.26, respectively) were normal at baseline. Repeated-measures analysis revealed significant declines in BMD and BMC Z-scores over the 100 day study period, when adjusted for age, sex, Tanner stage, lean mass, fat mass, resting energy expenditure, total energy intake, insulin sensitivity, serum phosphorus, and inpatient steroid intake. Adjusted mean (SE) 25OHD concentrations declined from 29.2 (3.1) ng/ml at baseline, to 17.7 (1.8) ng/ml at 100 days after HCT. Vitamin D deficiency (25OHD <20 ng/ml) was present in 50% of patients 100 days after HCT. CONCLUSIONS:Significant bone loss and vitamin D deficiency occur in children in the first 100 days following allogeneic HCT. Strategies to diminish acute bone loss during HCT in children are needed.
RCT Entities:
BACKGROUND: Hematopoietic cell transplantation (HCT) may be detrimental to bone health and vitamin D status in children. PROCEDURE: We conducted a prospective, multicenter cohort study to identify changes in bone health markers during the first 100 days after allogeneic HCT in 26 children. Bone mineral density (BMD), bone mineral content (BMC), and serum 25-hydroxyvitamin D (25OHD) concentrations were measured at baseline, 30 days, and 100 days after HCT. RESULTS: Mean (SD) BMD and BMC Z-scores (-0.48 ± 1.09 and -0.98 ± 1.26, respectively) were normal at baseline. Repeated-measures analysis revealed significant declines in BMD and BMC Z-scores over the 100 day study period, when adjusted for age, sex, Tanner stage, lean mass, fat mass, resting energy expenditure, total energy intake, insulin sensitivity, serum phosphorus, and inpatient steroid intake. Adjusted mean (SE) 25OHD concentrations declined from 29.2 (3.1) ng/ml at baseline, to 17.7 (1.8) ng/ml at 100 days after HCT. Vitamin D deficiency (25OHD <20 ng/ml) was present in 50% of patients 100 days after HCT. CONCLUSIONS: Significant bone loss and vitamin D deficiency occur in children in the first 100 days following allogeneic HCT. Strategies to diminish acute bone loss during HCT in children are needed.
Authors: Jill H Simmons; Eric J Chow; Elizabeth Koehler; Adam Esbenshade; Lesley-Ann Smith; Jean Sanders; Debra Friedman Journal: Pediatr Blood Cancer Date: 2010-12-22 Impact factor: 3.167
Authors: Lori J Bechard; Henry A Feldman; Catherine Gordon; Kathleen Gura; Andrew Sonis; Kathryn Leung; Robert Venick; Eva C Guinan; Christopher Duggan Journal: Contemp Clin Trials Date: 2010-01-03 Impact factor: 2.226
Authors: Amy D DiVasta; Henry A Feldman; Ashley E Quach; Maria Balestrino; Catherine M Gordon Journal: J Clin Endocrinol Metab Date: 2009-02-17 Impact factor: 5.958
Authors: G A M Faulhaber; M O Premaor; H L Moser Filho; L M Silla; T W Furlanetto Journal: Bone Marrow Transplant Date: 2009-04-13 Impact factor: 5.483
Authors: Babette S Zemel; Mary B Leonard; Andrea Kelly; Joan M Lappe; Vicente Gilsanz; Sharon Oberfield; Soroosh Mahboubi; John A Shepherd; Thomas N Hangartner; Margaret M Frederick; Karen K Winer; Heidi J Kalkwarf Journal: J Clin Endocrinol Metab Date: 2010-01-26 Impact factor: 5.958
Authors: N Di Iorgi; E Calandra; A Secco; F Napoli; A Calcagno; M Ghezzi; C Frassinetti; F De Terlizzi; G Giorgiani; F Locatelli; M Maghnie Journal: J Endocrinol Invest Date: 2010-01-22 Impact factor: 4.256
Authors: K Robien; L G Strayer; N Majhail; D Lazovich; K S Baker; A R Smith; D A Mulrooney; L J Burns Journal: Bone Marrow Transplant Date: 2011-01-17 Impact factor: 5.483